Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 2/3 1

Status

Completed 4Terminated 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5Tumor-Agnostic 3Head & Neck 2Genitourinary 2Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Breast Neoplasms 22Neoplasm Metastasis 5Triple Negative Breast Neoplasms 4Ovarian Neoplasms 3Pancreatic Neoplasms 2Hereditary Sensory and Autonomic Neuropathies 2Colorectal Neoplasms 2Brain Neoplasms 2Stomach Neoplasms 1Recurrence 1Pre-menopausal Breast Cancer 1Neoplasms 1Lung Neoplasms 1Glioblastoma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Paclitaxel 50Capecitabine 50Trastuzumab 38Fulvestrant 31pembrolizumab 27Cyclophosphamide 27Carboplatin 27Gemcitabine 23Letrozole 21palbociclib 19Docetaxel 19Lapatinib 18Bevacizumab 18exemestane 17eribulin 15Everolimus 14abemaciclib 13Vinorelbine 13Nivolumab 13Magnetic Resonance Spectroscopy 12Cisplatin 12Anastrozole 12trastuzumab deruxtecan 11Zoledronic Acid 11Doxorubicin 11Albumin-Bound Paclitaxel 11olaparib 10Tamoxifen 10Specimen Handling 10Radiotherapy 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Neoplasm Metastasis × NVP-BKM120 × Breast × Clear all
NCT01629615 2020-10-28

A Trial of BKM120 (a PI3K Inhibitor) in Patients With Triple Negative Metastatic Breast Cancer

SOLTI Breast Cancer Research Group

Phase 2 Completed
50 enrolled 10 charts
Breast

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT01610284 2020-08-25

BELLE-2

Novartis

Phase 3 Completed
1,147 enrolled 20 charts
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01633060 2019-01-30

BELLE-3

Novartis

Phase 3 Terminated
432 enrolled 20 charts
Breast

Breast Neoplasms, Neoplasm Metastasis, Hereditary Sensory and Autonomic Neuropathies

NCT01790932 2019-01-23

BKM120 For Triple Negative Breast Cancer

Dana-Farber Cancer Institute

Phase 2 Completed
50 enrolled 8 charts
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01572727 2017-03-09

BELLE-4

Novartis

Phase 2/3 Completed
416 enrolled 11 charts
Breast

Breast Neoplasms, Neoplasm Metastasis, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡